| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:53 UTC |
|---|
| HMDB ID | HMDB0015158 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Felodipine |
|---|
| Description | Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension. |
|---|
| Structure | CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | ChEBI | | 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate | ChEBI | | 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester | ChEBI | | Felodipina | ChEBI | | Felodipinum | ChEBI | | Plendil | Kegg | | (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid | Generator | | 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylic acid | Generator | | 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate ethyl methyl ester | Generator | | DL-Felodipine | HMDB | | 1a Brand OF felodipine | HMDB | | Alpharma brand OF felodipine | HMDB | | AstraZeneca brand OF felodipine | HMDB | | Azupharma brand OF felodipine | HMDB | | Felo biochemie | HMDB | | Felo puren | HMDB | | Felobeta | HMDB | | Felodur | HMDB | | Heumann brand OF felodipine | HMDB | | Hoechst brand OF felodipine | HMDB | | Pharmacia spain brand OF felodipine | HMDB | | TheraPharm brand OF felodipine | HMDB | | Felo-puren | HMDB | | Felocor | HMDB | | Felodipin heumann | HMDB | | Felodipin stada | HMDB | | Felodipin dura | HMDB | | Munobal | HMDB | | Pharmaceutica astra brand OF felodipine | HMDB | | Wörwag brand OF felodipine | HMDB | | CT Arzneimittel brand OF felodipine | HMDB | | CT-Arzneimittel brand OF felodipine | HMDB | | Aliud brand OF felodipine | HMDB | | Alphapharm brand OF felodipine | HMDB | | Astra brand OF felodipine | HMDB | | BC Brand OF felodipine | HMDB | | Felodipin al | HMDB | | Felodipin azu | HMDB | | Felodipin ratiopharm | HMDB | | Merck dura brand OF felodipine | HMDB | | Perfudal | HMDB | | Promed brand OF felodipine | HMDB | | Stadapharm brand OF felodipine | HMDB | | Betapharm brand OF felodipine | HMDB | | Felodipin von CT | HMDB | | AbZ brand OF felodipine | HMDB | | Agon | HMDB | | Aventis brand OF felodipine | HMDB | | Felodipin 1a pharma | HMDB | | Felodipin abz | HMDB | | Felodipin-ratiopharm | HMDB | | Felogamma | HMDB | | Fensel | HMDB | | Flodil | HMDB | | Heumann, felodipin | HMDB | | Hexal brand OF felodipine | HMDB | | Modip | HMDB | | Renedil | HMDB | | Ratiopharm brand OF felodipine | HMDB | | Von CT, felodipin | HMDB |
|
|---|
| Chemical Formula | C18H19Cl2NO4 |
|---|
| Average Molecular Weight | 384.254 |
|---|
| Monoisotopic Molecular Weight | 383.069113515 |
|---|
| IUPAC Name | 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
|---|
| Traditional Name | felodipine |
|---|
| CAS Registry Number | 72509-76-3 |
|---|
| SMILES | CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC |
|---|
| InChI Identifier | InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3 |
|---|
| InChI Key | RZTAMFZIAATZDJ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dihydropyridinecarboxylic acids and derivatives. Dihydropyridinecarboxylic acids and derivatives are compounds containing a dihydropyridine moiety bearing a carboxylic acid group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Hydropyridines |
|---|
| Direct Parent | Dihydropyridinecarboxylic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dihydropyridinecarboxylic acid derivative
- 1,2-dichlorobenzene
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Vinylogous amide
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Methyl ester
- Amino acid or derivatives
- Carboxylic acid ester
- Carboxylic acid derivative
- Secondary aliphatic amine
- Enamine
- Secondary amine
- Azacycle
- Organonitrogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Amine
- Organohalogen compound
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organochloride
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 145 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0072 g/L | Not Available | | LogP | 3.8 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.2 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 18.1689 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.65 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2950.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 505.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 190.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 278.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 110.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 615.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 891.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 82.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1466.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 662.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1903.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 520.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 459.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 490.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 257.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 33.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Felodipine,1TMS,isomer #1 | CCOC(=O)C1=C(C)N([Si](C)(C)C)C(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl | 2629.2 | Semi standard non polar | 33892256 | | Felodipine,1TMS,isomer #1 | CCOC(=O)C1=C(C)N([Si](C)(C)C)C(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl | 2266.2 | Standard non polar | 33892256 | | Felodipine,1TMS,isomer #1 | CCOC(=O)C1=C(C)N([Si](C)(C)C)C(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl | 3365.5 | Standard polar | 33892256 | | Felodipine,1TBDMS,isomer #1 | CCOC(=O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl | 2853.3 | Semi standard non polar | 33892256 | | Felodipine,1TBDMS,isomer #1 | CCOC(=O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl | 2491.2 | Standard non polar | 33892256 | | Felodipine,1TBDMS,isomer #1 | CCOC(=O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl | 3396.5 | Standard polar | 33892256 |
|
|---|